In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genexine Inc.

Latest From Genexine Inc.

Coronavirus Update: Sinovac Gets $15m Towards CoronaVac Phase II, Remdesivir Early Access In UK

Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares. 

Coronavirus COVID-19 BioPharmaceutical

Coronavirus Update: Rapid Japan Approval For Remdesivir, Combination With Lilly's Olumiant Is Next Hope

Plus: Chugai enters into Singapore research alliance, Korean consortium reports vaccine progress.

Coronavirus COVID-19 Research & Development

Genexine’s DNA Vaccine Shows Promise As Combo Therapy In Cervical Cancer

Genexine is poised to continue to focus on developing therapeutic DNA vaccine GX-188E as combination therapy, following Phase II interim results in advanced cervical cancer that show impressive clinical benefit over pembrolizumab monotherapy.

Research & Development Cancer

AnGes Takes DNA Vaccine Tack As It Enters Virus R&D Fray

Japanese bioventure goes down the DNA vaccine route, along with several others worldwide, pointing to potential development speed and safety advantages.

Japan Coronavirus COVID-19
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Dermatology
  • Gastrointestinal
  • Immune Disorders
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Alias(es)
  • Genexine Co. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Genexine Inc.
  • Senior Management
  • Young Chul Sung , PhD, CTO
    Tae Kim, PhD, VP, Clin. Operations
    Kyudon Kim, EVP, COO
  • Contact Info
  • Genexine Inc.
    Phone: (82) 31 628 3200
    700 Daewangpangyo-ro, Korea Bio Park
    Bldg. B
    Bundang-gu, Seongnam-si,, 13488
    South Korea